EnteroMedics Inc.'s (Nasdaq: ETRM) vBloc Neurometabolic Therapy is now available at MedStar Health in Maryland and Roper St. Francis in South Carolina. Shares of the medical device maker leaped $1.88 to close at $3.97.
EnteroMedics' vBloc Neurometabolic Therapy expands availability
January 05, 2017 at 17:58 PM EST
